Top Markets
Coin of the day
Bio-Path Holdings, Inc. Bio-Path Holdings, Inc.

Bio-Path Holdings, Inc.

BPTH
Classement en actions #39844
Bio-Path Holdings, Inc. is a U.S.-based pharmaceutical company focused on... Bio-Path Holdings, Inc. is a U.S.-based pharmaceutical company focused on developing RNAi nanoparticle drugs for oncology, with programs spanning both clinical and preclinical stages. Its innovative product development is centered around the DNAbilize platform, a drug delivery and antisense technology that employs a P-ethoxy modified deoxyribonucleic acid (DNA) backbone. This modification is specifically engineered to shield the DNA from premature degradation. The company's lead drug candidate, prexigebersen, is presently in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. Additionally, Bio-Path is advancing Liposomal Bcl-2 for refractory/relapsed lymphoma and chronic lymphocytic leukemia. Another promising asset, Liposomal STAT3, is in preclinical development, targeting pancreatic cancer, non-small cell lung cancer, and AML. Furthermore, prexigebersen-A is under development for various solid tumors. Bio-Path Holdings, Inc., founded in 2007, is headquartered in Bellaire, Texas.
Prix de l'action
$0.035
Dernière synchronisation: 2026-08-13
Capitalisation boursière
$326.98K
Changement (1 jour)
-12.50%
Changement (1 an)
-74.55%
Pays
US
Échange Bio-Path Holdings, Inc. (BPTH)

Catégorie

Le prix BPTH avec la capitalisation boursière de B
Bio-Path Holdings, Inc. Bio-Path Holdings, Inc.
BPTH
$0.035
Capitalisation boursière de Bio-Path Holdings, Inc.(BPTH)
Capitalisation boursière: $326.98K
En August 2026, Bio-Path Holdings, Inc. a une capitalisation boursière de $326.98K. Cela fait de Bio-Path Holdings, Inc. la 39844th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Bio-Path Holdings, Inc. du 2006 au 2026
BPTH par rapport au top 5 des plus populaires stocks
Prix pour BPTH L’actif B La capitalisation boursière de B Résultats
Bio-Path Holdings, Inc. Bio-Path Holdings, Inc.
$585,469 $326.98K
$5.470T +1,672,769,463.37%
Bio-Path Holdings, Inc. Bio-Path Holdings, Inc.
$478,163 $326.98K
$4.467T +1,366,181,294.03%
Bio-Path Holdings, Inc. Bio-Path Holdings, Inc.
$446,834 $326.98K
$4.174T +1,276,668,376.00%
Bio-Path Holdings, Inc. Bio-Path Holdings, Inc.
$396,063 $326.98K
$3.700T +1,131,608,631.24%
Bio-Path Holdings, Inc. Bio-Path Holdings, Inc.
$305,534 $326.98K
$2.854T +872,954,395.42%